Production and characterization of a human lysosomal recombinant iduronate-2-sulfatase produced in Pichia pastoris-Reference-Cited by-同舟云学术

Production and characterization of a human lysosomal recombinant iduronate-2-sulfatase produced in Pichia pastoris

Published:2018-04-23 Issue:5 Volume:65 Page:655-664
ISSN:0885-4513
Container-title:Biotechnology and Applied Biochemistry
language:en
Short-container-title:Biotechnology and Applied Biochemistry

Author:

Pimentel Natalia¹,Rodríguez-Lopez Alexander¹²,Díaz Sergio¹,Losada Juan C.¹,Díaz-Rincón Dennis J.¹,Cardona Carolina¹,Espejo-Mojica Ángela J.¹,Ramírez Aura M.¹,Ruiz Fredy³,Landázuri Patricia⁴,Poutou-Piñales Raúl A.⁵^ORCID,Cordoba-Ruiz Henry A.²,Alméciga-Díaz Carlos J.¹^ORCID,Barrera-Avellaneda Luis A.¹

Affiliation:

1. Institute for the Study of Inborn Errors of Metabolism; Faculty of Science; Pontificia Universidad Javeriana; Bogotá Colombia

2. Chemical Department; Faculty of Science; Pontificia Universidad Javeriana; Bogotá D.C. Colombia

3. Control; Power Electronics and Management of Technological Innovation (CEPIT); Electronic Engineering Department; Pontificia Universidad Javeriana; Bogotá D.C. Colombia

4. Research Group on Cardiovascular and Metabolic Diseases (GECAVYME); Faculty of Health Sciences; University of Quindío; Armenia-Quindío Colombia

5. Grupo de Biotecnología Ambiental e Industrial (GBAI); Faculty of Science; Pontificia Universidad Javeriana; Bogotá D.C. Colombia

Funder

Departamento Administrativo de Ciencia, Tecnología e Innovación

Pontificia Universidad Javeriana

Publisher

Wiley

Subject

Process Chemistry and Technology,Drug Discovery,Applied Microbiology and Biotechnology,Biomedical Engineering,Molecular Medicine,General Medicine,Bioengineering,Biotechnology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/bab.1660/fullpdf

Reference63 articles.

1. Safety and efficacy of enzyme replacement therapy with idursulfase beta in children aged younger than 6years with Hunter syndrome

2. Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome

3. Mucopolysaccharidosis type II: European recommendations for the diagnosis and multidisciplinary management of a rare disease

4. A biochemical and physicochemical comparison of two recombinant enzymes used for enzyme replacement therapies of hunter syndrome

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of Orthosteric and Allosteric Pharmacological Chaperones for Mucopolysaccharidosis Type IIIB;ChemBioChem;2024-07-16

2. Human Recombinant Lysosomal β-Hexosaminidase A produced in P.pastoris efficiently reduced GM2 ganglioside accumulation in Tay- Sachs Disease;2024-07-12

3. Novel human recombinant N-acetylgalactosamine-6-sulfate sulfatase produced in a glyco-engineered Escherichia coli strain;Heliyon;2024-06

4. Effect of two preservation methods on the viability and enzyme production of a recombinant Komagataella phaffii (Pichia pastoris) strain;Cryobiology;2021-12

5. Methanol addition after glucose depletion improves rPOXA 1B production under the pGap in P. pastoris X33: breaking the habit;SN Applied Sciences;2021-01